Brain Metabolism Observed at 3 Tesla or 7 Tesla in Health and Metabolic Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16-80
SponsorWeill Medical College of Cornell University

About this trial

The goal is to develop methodology to monitor flux in the citric acid cycle in brain via 13C nuclear magnetic resonance (NMR) spectroscopy at 7 Tesla or 3 Tesla.

Eligibility criteria

Qualifiers

Subjects will be adolescents or adults, age 16-80 years in good general health (evidenced by normal vital signs and no acute signs or symptoms of illness) or with previously (not for this study) documented G1D (genetically confirmed).

Ages 16 to 80

Persons with dental fillings, dental crowns, and short (max.4 cm) dental retainer wires can be included.

Disqualifiers

People or patients with uncontrolled seizure disorder, defined as grand mal (not absence) seizure in the preceding 3 months.

Pregnant females will be excluded. A serum or urine pregnancy test will be administered to all females of child bearing potential within 24 hours of administration of the tracer and MRI scan. The pregnancy test will be communicated in person by the study PI. Positive results in subjects 17 years old or younger will be disclosed to parent/guardian only.

Subjects with typical implanted orthopedic metal in bone may be considered for inclusion in a 7T scan providing the implant is not within the volume of the radio frequency coil. The PI and the AIRC Medical Director will discuss each case and determine eligibility.

Persons with ICD, pacemakers, neurostimulators and other such devices will be excluded.

Trial design

Treatments tested in this trial

  • Magnetic resonance imaging

Treatment groups

20 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Weill Medical College of Cornell University

Lead sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator